Actively Recruiting
Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)
Led by Associazione Italiana Ematologia Oncologia Pediatrica · Updated on 2024-04-15
150
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
Sponsors
A
Associazione Italiana Ematologia Oncologia Pediatrica
Lead Sponsor
I
Istituto Giannina Gaslini
Collaborating Sponsor
AI-Summary
What this Trial Is About
To describe the natural history of peripheral neuroblastic tumour presenting with SCI and evaluate the combined effects of different risk factors on the eventual neurologic and orthopaedic outcomes
CONDITIONS
Official Title
Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of peripheral neuroblastic tumour (neuroblastoma, ganglioneuroblastoma, ganglioneuroma) presenting with spinal canal involvement, symptomatic or asymptomatic, regardless of disease stage or clinical course
- No chemotherapy except steroids in the last 6 months
- Age under 18 years
- Planned follow-up of at least 5 years
- Written informed consent from parent or patient
You will not qualify if you...
- Invasion limited to intervertebral foramina only
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Giannina Gaslini
Genova, Italy, 16147
Actively Recruiting
Research Team
R
Riccardo Haupt, MD
CONTACT
T
tiziana landi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here